TCS, HDFCBANK, SBI Liquid Fund (G)
Panacea Biotec Ltd.
Panacea Biotec
NSE
₹ 0.00
0.00 (0.00)%
Healthcare
Small-cap
With a market cap of ₹18.90L Cr.
Moderate Volatility
Stock is 1.13x as volatile as index
| EX-Date | Purpose |
|---|---|
| 02 06 2021 | Audited Results |
| 23 07 2021 | Quarterly Results |
| 12 11 2021 | Quarterly Results |
| 01 02 2022 | Inter alia, to consider and approve the proposal of raising funds in such manner and on such terms as may be decided by the Board of Directors of the Company and / or its subsidiary company, subject to such regulatory /statutory approvals as may be required. The Board would also consider convening Extra-ordinary General Meeting of its shareholders for seeking their approval in accordance with the relevant provisions of the Act. |
| 14 02 2022 | Quarterly Results |
| 18 05 2022 | Audited Results |
| 09 08 2022 | Quarterly Results |
| 14 11 2022 | Quarterly Results |
| 14 02 2023 | Quarterly Results |
| 30 05 2023 | Audited Results |
| 12 08 2023 | Quarterly Results |
| 10 11 2023 | Quarterly Results |
| 13 02 2024 | Quarterly Results |
| 13 11 2024 | Quarterly Results Inter-alia, to consider and approve raising of funds through External Commercial Borrowings from DFC for an amount uptoUS$ 20 million (equivalent to (Rs.168.16 Crore), in one or more tranches, as may be permitted under applicable laws. |
| 14 02 2025 | Quarterly Results |
News
No News data available
